Review of my portfolio from 1 to 7 June 2021

 Here is a sharing of my personal portfolio.

 

For the week of 1 to 7 June, it jumped to 4.25%. It has outperformed the 2800 HK Tracker Fund of Hong Kong from 23 Mar to now. The Vanguard Total World Stock ETF is up 5.95% (VT) and S&P 500 ETF (SPY) is up 6.53%. That’s why I also mentioned that it is strongly advisable to have a good global equity fund like Morgan Stanley Global Brands / Blackrock Global Equity Income, and a good US equity fund like Franklin US Opportunities or JPMorgan US Small Caps. This tracking allows me to know where my mistakes are, and correct them quickly.

 

 


XIRR is 22.73%. We are off to a good start and I hope this continues. 



 

The “catch-up” with the VT benchmark occurred when I overweighted Chinese stocks and ETF. For ETF, I added 2823 HK, or ASHR US ETF. For funds, UBS China A Opportunities and JPMorgan China A Opportunities. The old economy stocks in China (Wuliangye, Kweichou Maotai, China Merchant Bank) seem to have recovered. The Chinese tech is still lagging but appear to be bottoming up. I devised a momentum tracker of major indices (e.g. Asia ex Japan, Emerging Markets, Europe and US), and sectors (energy, mining, tech, healthcare, financial institutions). Whenever a sector or country shows positive or negative momentum, I overweight / underweight the stocks, etf and funds.

 

 



 

For country weights, I am at 73% US stocks. This is my NEUTRAL position. Singapore stocks, mainly REITS and banks, have fallen to 9.9%. Chinese equities has risen from 12 to 17% due to positive momentum.

 

 





 

Top performing stocks from 23 Mar 21 to now.

 

  1. Microstrategy because I shorted it. It holds a lot of bitcoin which I felt was over-hyped and will crash. I may close this position once I see Bitcoin stabilising.
  2. A50 shares is up 16%. This is a big position and is up 16% within 2 weeks. (try JPMorgan China A Opportunities and UBS China A Opportunities)
  3. Yum China. KFC, Pizza Hut in China. Resilient business. Clogging up the arteries and boosting cancer rates in China. I was in Tianjin a few years ago and saw street signs of KFC every few hundred metres. Got me worried about the health implications.
  4. Moderna. I’ve re-opened my position in the “King of Vaccines”. Up 13.7%.
  5. Facebook. 12.1%. Try Polar Capital Technology.
  6. Meiituan. Reopened position. Up 12.1%. It’s over-valued, pricey. But food deliveries, hotel bookings should rise due to re-opening.
  7. Energy Fund. Up 10.7%. Try Blackrock World Energy.
  8. Unitedhealth Group. Biggest healthcare insurance in the US. Try Wellington Healthcare.

 



 

 

Worst Performing:

  1. ARK Innovation. Down 15.9%. Notice my position is small. This is a speculative bet and it’s down 15.9%. small position of USD429.67.
  2. Square is down 15.8%. Again a small position of USD422.86.
  3. ARK Genomic Revolution down 12.7%. Small position of USD395.90.
  4. MercadoLibre. Down 12%. Latin America’s biggest e-commerce. I intend to add more positions. Fundamentally strong. Low debt, rising revenues and profits. Stable margins.
  5. Lemonade. Down 12%. Small position of 374.32.  Online insurance in the US.



 

Now comes the transactions for the week!

  1. Closed my Boeing shorts and went long. This is a strong company that’s on the rise. Duopoly.
  2. iShares US Aerospace. Defence spending will continue to rise in the US due to the rising China – US tension.
  3. NXP Semicon, ASML Hlg, Applied Materials. Notice I added 3 semicon related stocks to my portfolio due to momentum. This is in addition to Taiwan Semicon and Lam Research which I already own. Polar Cap Tech and Blackrock World Tech owns a few semicon companies as well.
  4. Moderna. Re-opened long position. Healthcare. Wellington Healthcare.
  5. Meituan and Hong Kong Exchange. For funds I will add UBS China A Opportunities and JPMorgan China A Opportunities.

 



 

Good luck for the rest of the week and stay safe.

Comments

Popular posts from this blog

22 Jul portfolio review (Model Portfolio)

My Funds Portfolio 14 Jan 2021

This Too Shall Pass